Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis
International Journal of Molecular Sciences · 08.12.2024 · 25 (23) · 13190
DOI: 10.3390/ijms252313190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.12.2024. Verfasst von Dang-Khoa Vo und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea. Hauptthemen laut MEDLINE: Metabolomics, Precision Medicine, Biomarkers. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolomics has come to the fore as an efficient tool in the search for biomarkers that are critical for precision health approaches and improved diagnostics. This review will outline recent advances in biomarker discovery based on metabolomics, focusing on metabolomics biomarkers reported in cancer, neurodegenerative disorders, cardiovascular diseases, and metabolic health. In cancer, metabolomics provides evidence for unique oncometabolites that are important for early disease detection and monitoring of treatment responses. Metabolite profiling for conditions such as neurodegenerative and mental health disorders can offer early diagnosis and mechanisms into the disease especially in Alzheimer’s and Parkinson’s diseases. In addition to these, lipid biomarkers and other metabolites relating to cardiovascular and metabolic disorders are promising for patient stratification and personalized treatment. The gut microbiome and environmental exposure also feature among the influential factors in biomarker discovery because they sculpt individual metabolic profiles, impacting overall health. Further, we discuss technological advances in metabolomics, current clinical applications, and the challenges faced by metabolomics biomarker validation toward precision medicine. Finally, this review discusses future opportunities regarding the integration of metabolomics into routine healthcare to enable preventive and personalized approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.
- BioNano Applications Research Center, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Dang-Khoa Vo
Zitieren
APA
Vo, D. K., & Trinh, K. T. L. (2024). Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis. International Journal of Molecular Sciences, 25(23), 13190. https://doi.org/10.3390/ijms252313190
Vancouver
Vo DK, Trinh KTL. Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis. International Journal of Molecular Sciences. 2024;25(23):13190. doi:10.3390/ijms252313190
BibTeX
@article{Vo2024,
author = {Vo, Dang-Khoa and Trinh, Kieu The Loan},
title = {Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13190},
doi = {10.3390/ijms252313190}
}
EUVIMED